Recursion Pharmaceuticals Intangible Assets

Recursion Pharmaceuticals (RXRX) currently reports a intangible assets of $280M as of June 2026. That compares with $340M in the prior-year period — down 17.1% year over year. Use the charts on this page to explore Recursion Pharmaceuticals's intangible assets history and peer comparisons.

Recursion Pharmaceuticals's intangible assets decreased from $340M to $280M — a 17.1% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Recursion Pharmaceuticals reported $280M in intangible assets as of June 2026. That compares with $340M in the prior-year period — down 17.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $280M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Recursion Pharmaceuticals, and consider following RXRX for alerts when major investors trade the stock.

Recursion Pharmaceuticals is classified in the Healthcare sector. On intangible assets, it currently shows $280M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RXRX with unrelated industries.